Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
94 participants
INTERVENTIONAL
2016-03-31
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Childhood Obesity Treatment - Telephone Coaching vc Usual Care
NCT02794090
A Three-year Behavioral Treatment of Obese Children
NCT01029964
Childhood Overweight
NCT00916318
Group Sessions and Web-based Treatment Targeting Children With Obesity Age 5-12 Years and Their Families
NCT04013230
Lifestyle Counseling and Medication for Adolescent Weight Management
NCT04873245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
With 60 patients in each group, the study has 80% statistical power at 5% significance level to detect an average difference between the treatment groups in the intra-individual change in the BMI Z-score that is 0.51 x the standard deviation in the intra-individual change. Previous data from the investigators own group suggest that a reasonable estimate of the standard deviation in the intra-individual change in the BMI Z-score following intervention is 0.42. Thus, the study has 80% statistical power at 5% significance level to detect a difference in the intra-individual change in the BMI Z-score that is 0.51 x 0.42 = 0.21 on average. The study will with the present funding end its follow up in June 2017.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SOFT
All Children have their first and their last consultation at The Child Obesity Unit.
The investigators use Standardized Obesity Family Therapy "SOFT" as described by Nowicka \& Flodmark (1-3). The intervention use psychological techniques developed in systemic family therapy applied on advice regarding exercise and diet as well as behavioural Life style Changes.
At each consultation with the overweight child and his/her biological parents there are two therapists present.
SOFT
SOFT is based on systemic and solution-focused theories to change lifestyle and has shown positive effects on children with respect to the degree of obesity, physical fitness, self-esteem and family functioning.
TeleSOFT
The same method Lifestyle intervention "SOFT" is used. The only difference is that the communication in the second, third (and fourth) visit is made by use of video on distance. The investigators use Standardized Obesity Family Therapy "SOFT" as described by Nowicka \& Flodmark (1-3).
TeleSOFT
The therapists communicate with the overweight child and his/her family by the SOFT method on distance by use of video.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SOFT
SOFT is based on systemic and solution-focused theories to change lifestyle and has shown positive effects on children with respect to the degree of obesity, physical fitness, self-esteem and family functioning.
TeleSOFT
The therapists communicate with the overweight child and his/her family by the SOFT method on distance by use of video.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 9 years, 6 months =\> AGE \< 10 Years AND 19,5 \<BMI\<23,5
* 10 years = AGE \< 10 years, 6 months AND 20,0\<BMI\<24,0
* 10 years, 6 months=\>AGE\< 11 years AND 20,5\<BMI\<24,5
* 11 years = AGE \< 11 years, 6 months AND 21,0\<BMI\<25,5
* 11 years, 6 months =\>AGE\<12 years AND 21,5\<BMI\<25,5
Exclusion Criteria
* Children with monogenic obesity
* Present less than 80% at school in the latest school year.
* No foster care for the child or his/her brothers or sisters
9 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Skane University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carl-Erik Flodmark
Docent
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Agardh, Professor
Role: STUDY_CHAIR
Skane University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barnmedicin
Malmo, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nowicka P, Pietrobelli A, Flodmark CE. Low-intensity family therapy intervention is useful in a clinical setting to treat obese and extremely obese children. Int J Pediatr Obes. 2007;2(4):211-7. doi: 10.1080/17477160701379810.
Flodmark CE, Ohlsson T, Ryden O, Sveger T. Prevention of progression to severe obesity in a group of obese schoolchildren treated with family therapy. Pediatrics. 1993 May;91(5):880-4.
Nowicka P, Flodmark CE. Family therapy as a model for treating childhood obesity: useful tools for clinicians. Clin Child Psychol Psychiatry. 2011 Jan;16(1):129-45. doi: 10.1177/1359104509355020. Epub 2010 Jul 22.
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000 May 6;320(7244):1240-3. doi: 10.1136/bmj.320.7244.1240.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.